Logos Global Management »

Rayzebio shares owned by Logos Global Management

Quarter-by-quarter ownership of Rayzebio shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Rayzebio

Tip: Access up to 7 years of quarterly data

All positions including Rayzebio held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rayzebio by Logos Global Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $35M 568k 62.17

More positions owned by Logos Global Management

Cytokinetics Com New (CYTK)
Apellis Pharmaceuticals (APLS)
Sarepta Therapeutics Call Option (SRPT)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Olema Pharmaceuticals (OLMA)
Immunovant (IMVT)
Structure Therapeutics Sponsored Ads (GPCR)
Rocket Pharmaceuticals (RCKT)
Rayzebio
Ambrx Biopharma
Karuna Therapeutics Ord
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Morphosys Sponsored Ads Call Option (MOR)

View all positions for Logos Global Management

Top funds holding Rayzebio

Viking Global Investors
venBio Partners
VR Adviser
Wellington Management Company
OrbiMed Advisors
Redmile Group
Samsara BioCapital
Fairmount Funds Management
Cormorant Asset Management
Vanguard Group
Hillhouse Capital Advisors
Deerfield Management Company
Alliancebernstein
Laurion Capital Management
Alpine Associates Management

View all funds holding Rayzebio